Fred Turner is the Chief Executive Officer and co-founder of Curative. A British scientist from West Yorkshire, Turner attended the University of Oxford. Turner was named one of the top 100 practicing scientists in the UK by the Science Council in 2013. He was also included in Forbes’ ‘30 Under 30’ list and ranked first in the European Union Contest for Young Scientists. Recently, Fred was awarded Comparably's Best CEO Award and Modern Healthcare’s Top 25 Emerging Leaders in 2021.
Under Turner’s leadership, Curative launched a first-of-its-kind health insurance plan that offers unmatched transparency into healthcare costs. Inspired by his vision to create a healthcare system that works for and supports patients’ whole health through every step of their personal health journey, Turner and the Curative team developed a path-breaking health plan with no copays, no deductibles, and no cost-sharing for its members.
Previously, Turner led Curative as it became the national leader in bringing COVID-19 testing and vaccine administration resources to people in response to the pandemic, providing more than 36 million tests and two million vaccines across thousands of locations in more than 40 states.
Prior to creating both of Curative’s highly innovative business models, Fred founded and led a 16z and YC-backed diagnostics (Dx) startup that built a CLIA lab for validating and launching an STD testing product in Menlo Park, California.